Datavault AI Inc. (DVLT) is a micro-cap (≈$471M) trading on Nasdaq with a second-in-twelve-months bid-price compliance notice. The Q1 2026 10-Q filed May 15, 2026 confirms a deeply distressed balance sheet. The new information isn't the distress — that's in the tape. It's that the only mechanism by which DVLT survives is a $120M term sheet from Scilex Holding (SCLX) — and SCLX filed a Notification of Late 10-Q on the same day, with its own auditor-flagged going concern.

What the filing says

Q1 2026: net loss $53.1M on revenue $3.4M; cash $2.2M; BTC down from $92.2M (1,054 units) to $57.1M (837 units). Operating burn $30.95M; total burn $53.1M after $16.8M crypto loss + $2.5M NYIAX impairment + $1.7M debt extinguishment.

The $30M of 2025 "revenue" from Scilex/Vivasor IP licenses produced $500K of Q1 cash. The receivable balance moved from $30.0M to $29.5M. On April 16, 2026, Vivasor (controlled by SCLX CEO Henry Ji) and DVLT executed a Subscription Agreement: DVLT issued 75.9M shares to Vivasor in exchange for $50M of Vivasor Series A equity at $6.125/share. Equity-for-equity; not cash collection. The 10-Q does not state whether this extinguishes the $29.5M AR.

A new mechanism appears: Scilex advanced $18.7M cash to DVLT at 15.42% annual interest during Q1. DVLT repaid by transferring 217 BTC ($18.2M) back to Scilex. The cash flow statement classifies it as "Settlement of Related Party Payable with Bitcoin." Net effect: Scilex converts BTC parked at DVLT back to cash at a 15% premium.

A direct related-party patent sale: Dr. Ji + SCLX CFO Stephen Ma sold a patent to DVLT for $5.4M in 7.5M shares.

Strategic direction shifted again. Term sheet with Scilex April 26 for "quantum-ready GPU infrastructure across ≈100 US cities," $120M Scilex contribution by Dec 31, 2026, revenue share 30%/15%/5% perpetual. Third pivot in 12 months. Term sheet language: "no assurance...will be consummated...or at all."

Share count: 573M (Dec 31, 2025) → 617M (March 31) → 855M (May 11). Pending: NYIAX merger 78.9M, CyberCatch LOI 49.9M. Path to >1B direct.

What the market thinks

Reverse-engineering the four-state scenario from the $0.55 print at filing and our endpoints — death-spiral $0.10, slow-grind $0.35, restructuring $0.26, scilex-rescue $1.32 — implies market probabilities approximately 25 / 35 / 10 / 30. The market is pricing roughly 30% odds on the Scilex rescue. Borrow on the name is expensive (sub-$1 microcap BTC-treasury), options are thin, short interest is 15.2% of float.

Why the gap exists

SCLX 10-K (filed April 10, 2026): $4.955M cash + $6.026M marketable = $11M liquid; total current liabilities $483.7M; stockholders' deficit -$211.8M; 2025 net loss $402M; auditor going concern doubt; Oramed senior debt deferred March 29; NT 10-Q filed May 15 citing Vivasor consolidation complexity; SCLX suing St. James Trust for $100M+ fraud, with St. James holding 85.8M DVLT shares as collateral on the Scilex-St. James loan. Mevi et al. v. Ji et al. invokes California Penal Code 496.

The DVLT and SCLX situations are operationally one failure mode. Treating them as independent is the market's error. Same-day NT 10-Q and 10-Q filings suggest cross-pollination is unfinished.

Our scenario put scilex-rescue at 10%, not 30%. That's the gap.

Risks (ranked)

1. Squeeze on 15.2% short interest if any GPU first-closing 8-K hits. -10% to -25% intraday possible.
2. BTC rally lifts the treasury and the bull narrative even without funding.
3. SCLX raises capital (equity, asset sale) and funds material fraction of $120M. Validates rescue state.
4. St. James settlement or SCLX win removes collateral overhang positively.
5. Vivasor delivers actual revenue materializing the IP license thesis (low probability given $678K FY2025 revenue per SCLX 10-K).

Catalysts

• Past May 20: SCLX Q1 10-Q (delinquent)
• ~June 16, 2026: NYIAX 90-day termination expiry
• Aug 24, 2026: Nasdaq bid-price compliance deadline
• Mid-Aug 2026: DVLT Q2 10-Q (BTC drain + AR collection visibility)
• Q3-Q4 2026: First $20M+ GPU closing 8-K window
• Ongoing: SCLX v. St. James Central District CA docket; Mevi v. Ji class cert

What would change our mind

• SCLX equity raise or asset sale ≥ $100M closes — rescue probability triples
• DVLT 8-K announcing first $20M+ GPU closing — bull validation
• Auditor signs FY2026 10-K with no going-concern qualification — bear thesis weakens materially
• Court ruling for SCLX v. St. James releasing the 85.8M DVLT collateral overhang positively

Evidence